Global Trials Focus
Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlight: Corticosteroids and cyclophosphamide may be superior to tacrolimus and rituximab in the treatment of primary membranous nephropathy at the cost of increased adverse events See the latest trials here. A summary of the highlighted trial is now available in French, Mandarin,...